Fig 1.
Flowchart of patient selection and grouping.
Table 1.
Comparison of general characteristics of patients with HUA among 25(OH)D level groups.
Table 2.
Comparison of laboratory data of patients with HUA among 25(OH)D level groups.
Table 3.
Comparison of CVD examination data for patients with HUA among 25(OH)D level groups.
Fig 2.
Comparison of CVD-related examination data among 25(OH)D level groups.
(A) Comparison of the number of cases with and without CVD among various 25(OH)D level groups; (B) Comparison of cumulative coronary artery branch counts among various 25(OH)D level groups; (C) Number of cases with different 25(OH)D levels and plaque outcomes. 25(OH)D, 25-hydroxyvitamin D; CVD, cardiovascular disease.
Fig 3.
Comparison of CVD-related scores among 25(OH)D level groups.
(A) Comparison of GS scores among 25(OH)D level groups; (B) Comparison of SIS scores among 25(OH)D level groups; (C) Comparison of SSS scores among 25(OH)D level groups. 25(OH)D, 25-hydroxyvitamin D; CVD, cardiovascular disease; GS, Gensini score; SIS, segment involvement score; SSS, segment stenosis score.
Table 4.
Correlation analysis between 25(OH)D and various indicators.
Fig 4.
Scatter plot of the correlation analysis between 25(OH)D and various indicators.
(A) Scatter plot of HbA1c and 25(OH)D levels; (B) Scatter plot of TC and 25(OH)D levels; (C) Scatter plot of TG and 25(OH)D levels; (D) Scatter plot of GS and 25(OH)D levels. 25(OH)D, 25-hydroxyvitamin D; GS, Gensini score; HbA1c, glycated hemoglobin; TC, total cholesterol; TG, triglycerides.
Table 5.
Single-factor logistic regression results.
Table 6.
Stepwise-adjusted logistic regression models.
Table 7.
Multivariate logistic regression results.
Table 8.
Sex and age-stratified regression results for 25(OH)D and CVD.